These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36406896)

  • 41. Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants.
    Puliyanda DP; Swinford R; Pizzo H; Garrison J; De Golovine AM; Jordan SC
    Pediatr Transplant; 2021 Mar; 25(2):e13850. PubMed ID: 33217125
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urine Donor-Derived Cell-Free DNA Helps Discriminate BK Polyomavirus-Associated Nephropathy in Kidney Transplant Recipients With BK Polyomavirus Infection.
    Chen XT; Chen WF; Li J; Deng RH; Huang Y; Yang SC; Chen PS; Jiang TY; Liu HT; Wang CX; Chen LZ; Qiu J; Huang G
    Front Immunol; 2020; 11():1763. PubMed ID: 32973745
    [No Abstract]   [Full Text] [Related]  

  • 43. Donor-derived cell-free DNA is associated with cardiac allograft vasculopathy.
    Holzhauser L; Clerkin KJ; Fujino T; Alenghat FJ; Raikhelkar J; Kim G; Sayer G; Uriel N
    Clin Transplant; 2021 Mar; 35(3):e14206. PubMed ID: 33368611
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between dd-cfDNA levels, de novo donor specific antibodies, and eGFR decline: An analysis of the DART cohort.
    Sawinski DL; Mehta S; Alhamad T; Bromberg JS; Fischbach B; Aeschbacher T; Ghosh S; Shekhtman G; Dholakia S; Brennan DC; Poggio E; Bloom RD; Jordan SC
    Clin Transplant; 2021 Sep; 35(9):e14402. PubMed ID: 34184326
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Donor-Derived Cell-Free DNA for Kidney Allograft Surveillance after Conversion to Belatacept: Prospective Pilot Study.
    Osmanodja B; Akifova A; Oellerich M; Beck J; Bornemann-Kolatzki K; Schütz E; Budde K
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983437
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extremely High Cell-free DNA Levels Observed in Renal Allograft Patient With SARS-CoV-2 Infection.
    Bunnapradist S; Datta N; Schaenman J; Ioannou N; Bloom MS; Malhotra M; Tabriziani H; Gauthier P; Ahmed E; Billings PR; Lum EL
    Transplant Direct; 2021 May; 7(5):e691. PubMed ID: 33912658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD).
    Keller M; Bush E; Diamond JM; Shah P; Matthew J; Brown AW; Sun J; Timofte I; Kong H; Tunc I; Luikart H; Iacono A; Nathan SD; Khush KK; Orens J; Jang M; Agbor-Enoh S
    J Heart Lung Transplant; 2021 Jun; 40(6):488-493. PubMed ID: 33814284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multi-centre analytical performance verification of an IVD assay to quantify donor-derived cell-free DNA in solid organ transplant recipients.
    Casas S; Tangprasertchai NS; Oikonomaki K; Mathers S; Sollet ZC; Samara S; Liu J; Burlinson ND; Constantoulakis P; Villard J; Viard T
    HLA; 2024 May; 103(5):e15518. PubMed ID: 38733247
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Absolute or Relative Quantification of Donor-derived Cell-free DNA in Kidney Transplant Recipients: Case Series.
    Osmanodja B; Akifova A; Budde K; Choi M; Oellerich M; Schütz E; Beck J
    Transplant Direct; 2021 Nov; 7(11):e778. PubMed ID: 34712778
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between donor-derived cell-free DNA and tissue-based rejection-related transcripts in heart transplantation.
    Lee DH; Usmani A; Wu R; Wicks T; Noh CY; Burke R; Ravichandran V; Wolf-Doty T; Dumitru I; Oliveira GH; Berman P; Mackie B
    J Heart Lung Transplant; 2024 Jul; 43(7):1118-1125. PubMed ID: 38373559
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Donor-derived Cell-free DNA and the Prediction of BK Virus-associated Nephropathy.
    Kant S; Bromberg J; Haas M; Brennan D
    Transplant Direct; 2020 Nov; 6(11):e622. PubMed ID: 33134498
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynamic Response of Donor-Derived Cell-Free DNA Following Treatment of Acute Rejection in Kidney Allografts.
    Wolf-Doty TK; Mannon RB; Poggio ED; Hinojosa RJ; Hiller D; Bromberg JS; Brennan DC
    Kidney360; 2021 Apr; 2(4):729-736. PubMed ID: 35373051
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Initiation of noninvasive surveillance for allograft rejection in heart transplant patients > 1 year after transplant.
    Kewcharoen J; Kim J; Cummings MB; Leitner KB; Suzuki EMB; Banerjee D; Lum CJ
    Clin Transplant; 2022 Mar; 36(3):e14548. PubMed ID: 34843112
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Causes of Renal Allograft Injury in Recipients With Normal Donor-derived Cell-free DNA.
    Xie WY; Kim K; Goussous N; Drachenberg CB; Scalea JR; Weir MR; Bromberg JS
    Transplant Direct; 2021 Apr; 7(4):e679. PubMed ID: 33688578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients.
    Jordan SC; Bunnapradist S; Bromberg JS; Langone AJ; Hiller D; Yee JP; Sninsky JJ; Woodward RN; Matas AJ
    Transplant Direct; 2018 Sep; 4(9):e379. PubMed ID: 30234148
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cell-Free DNA and CXCL10 Derived from Bronchoalveolar Lavage Predict Lung Transplant Survival.
    Yang JYC; Verleden SE; Zarinsefat A; Vanaudenaerde BM; Vos R; Verleden GM; Sarwal RD; Sigdel TK; Liberto JM; Damm I; Watson D; Sarwal MM
    J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30781765
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell-Free DNA and Active Rejection in Kidney Allografts.
    Bloom RD; Bromberg JS; Poggio ED; Bunnapradist S; Langone AJ; Sood P; Matas AJ; Mehta S; Mannon RB; Sharfuddin A; Fischbach B; Narayanan M; Jordan SC; Cohen D; Weir MR; Hiller D; Prasad P; Woodward RN; Grskovic M; Sninsky JJ; Yee JP; Brennan DC;
    J Am Soc Nephrol; 2017 Jul; 28(7):2221-2232. PubMed ID: 28280140
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic value of donor-derived cell-free DNA to predict antibody-mediated rejection in donor-specific antibody-positive renal allograft recipients.
    Mayer KA; Doberer K; Tillgren A; Viard T; Haindl S; Krivanec S; Reindl-Schwaighofer R; Eder M; Eskandary F; Casas S; Wahrmann M; Regele H; Böhmig GA
    Transpl Int; 2021 Sep; 34(9):1689-1702. PubMed ID: 34448270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study.
    Zhang H; Zheng C; Li X; Fu Q; Li J; Su Q; Zeng L; Liu Z; Wang J; Huang H; Xu B; Ye M; Liu L; Wang C
    Front Immunol; 2020; 11():342. PubMed ID: 32184785
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Donor-derived cell-free DNA predicted allograft rejection and severe microvascular inflammation in kidney transplant recipients.
    Kim HD; Bae H; Kang H; Lee H; Eum SH; Yang CW; Choi YJ; Chung BH; Oh EJ
    Front Immunol; 2024; 15():1433918. PubMed ID: 39044817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.